3-(Bromomethyl)-5-methylisoxazole → HCID 11709591, compound
Reaction equation
C(N1CCO[C@H](CC2C=CC=C(C=CC3C=NC=CC=3)C=2)C1)(OC(C)(C)C)=O.Br[CH2:30][C:31]1[CH:35]=[C:34]([CH3:36])[O:33][N:32]=1.C(OC([N:44]1[CH2:49][CH2:48][O:47][C@H:46]([CH2:50][C:51]2[CH:56]=[C:55]([F:57])[C:54]([OH:58])=[CH:53][C:52]=2[F:59])[CH2:45]1)=O)(C)(C)C>>[F:59][C:52]1[CH:53]=[C:54]([O:58][CH2:30][C:31]2[CH:35]=[C:34]([CH3:36])[O:33][N:32]=2)[C:55]([F:57])=[CH:56][C:51]=1[CH2:50][C@H:46]1[O:47][CH2:48][CH2:49][NH:44][CH2:45]1Participants
4
Procedure
The title compound was synthesized in analogy to Example 78, intermediate (a), using 3-(bromomethyl)-5-methylisoxazol and (R)-2-(2,5-difluoro-4-hydroxy-benzyl)-morpholine-4-carboxylic acid tert-butyl ester as starting materials.
Sources & evidence
- ORD record
- ord-0557e66b93bc4e7e9298bf34d859a59d
- Source dataset
- uspto-grants-2008_01
- Patent number
- US07323466B2
Reaction notes
Loading…